ING Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47M Buy
512,309
+184,378
+56% +$16.1M 0.23% 85
2026
Q1
$27.9M Buy
+327,931
New +$29.2M 0.17% 103
2025
Q4
Sell
-177,633
Closed -$14.2M 564
2025
Q3
$14.2M Buy
+177,633
New +$15.2M 0.08% 148
2025
Q2
Sell
-103,674
Closed -$9.71M 492
2025
Q1
$9.71M Sell
103,674
-725
-0.7% -$64.9K 0.07% 167
2024
Q4
$9.49M Sell
104,399
-4,928
-5% -$470K 0.06% 200
2024
Q3
$11.3M Sell
109,327
-1,122
-1% -$114K 0.07% 189
2024
Q2
$10.7M Sell
110,449
-2,538
-2% -$234K 0.06% 215
2024
Q1
$10.2M Buy
112,987
+105
+0.1% +$8.9K 0.07% 233
2023
Q4
$9M Sell
112,882
-447,145
-80% -$33.6M 0.07% 224
2023
Q3
$39.8M Sell
560,027
-80,719
-13% -$6.04M 0.35% 64
2023
Q2
$49.4M Buy
640,746
+274,727
+75% +$21.3M 0.37% 52
2023
Q1
$27.5M Buy
366,019
+217,724
+147% +$16.2M 0.27% 76
2022
Q4
$11.7M Sell
148,295
-282,625
-66% -$21.2M 0.12% 142
2022
Q3
$30.3M Buy
430,920
+272,858
+173% +$21.4M 0.51% 45
2022
Q2
$12.7M Buy
158,062
+7,561
+5% +$591K 0.15% 111
2022
Q1
$11.4M Buy
150,501
+39,769
+36% +$3.15M 0.12% 142
2021
Q4
$9.45M Buy
110,732
+38,826
+54% +$3.03M 0.08% 186
2021
Q3
$5.43M Buy
71,906
+969
+1% +$76.9K 0.07% 180
2021
Q2
$5.77M Buy
70,937
+10,857
+18% +$888K 0.09% 145
2021
Q1
$4.74M Buy
60,080
+16,545
+38% +$1.3M 0.1% 134
2020
Q4
$3.72M Buy
43,535
+33,542
+336% +$2.77M 0.08% 163
2020
Q3
$771K Buy
9,993
+5,731
+134% +$437K 0.03% 221
2020
Q2
$312K Sell
4,262
-8,437
-66% -$599K 0.01% 218
2020
Q1
$843K Sell
12,699
-40,528
-76% -$2.86M 0.04% 200
2019
Q4
$3.66M Sell
53,227
-3,808
-7% -$260K 0.11% 134
2019
Q3
$4.19M Sell
57,035
-96,056
-63% -$6.97M 0.11% 137
2019
Q2
$11M Buy
153,091
+5,065
+3% +$360K 0.19% 86
2019
Q1
$10.1M Buy
148,026
+104,774
+242% +$6.77M 0.22% 72
2018
Q4
$2.57M Sell
43,252
-38,796
-47% -$2.43M 0.06% 200
2018
Q3
$5.49M Buy
82,048
+17,996
+28% +$1.2M 0.09% 146
2018
Q2
$4.15M Sell
64,052
-66,030
-51% -$4.32M 0.08% 151
2018
Q1
$9.32M Sell
130,082
-5,845
-4% -$421K 0.17% 84
2017
Q4
$10.3M Buy
135,927
+2,736
+2% +$200K 0.17% 69
2017
Q3
$9.7M Buy
133,191
+24,477
+23% +$1.76M 0.19% 97
2017
Q2
$8.06M Sell
108,714
-4,937
-4% -$367K 0.15% 96
2017
Q1
$8.32M Sell
113,651
-24,138
-18% -$1.69M 0.15% 104
2016
Q4
$9.08M Buy
137,789
+59,882
+77% +$4.11M 0.17% 97
2016
Q3
$5.71M Buy
77,907
+4,088
+6% +$302K 0.07% 147
2016
Q2
$5.4M Buy
73,819
+2,354
+3% +$168K 0.07% 131
2016
Q1
$5.05M Sell
71,465
-78,488
-52% -$5.22M 0.06% 165
2015
Q4
$9.99M Buy
149,953
+43,848
+41% +$2.92M 0.06% 233
2015
Q3
$6.74M Buy
106,105
+13,137
+14% +$858K 0.05% 249
2015
Q2
$6.08M Sell
92,968
-37,524
-29% -$2.55M 0.03% 331
2015
Q1
$9.05M Sell
130,492
-36,261
-22% -$2.51M 0.05% 297
2014
Q4
$11.5M Sell
166,753
-16,139
-9% -$1.09M 0.05% 271
2014
Q3
$11.9M Sell
182,892
-19,072
-9% -$1.26M 0.07% 233
2014
Q2
$13.8M Buy
201,964
+22,139
+12% +$1.48M 0.07% 229
2014
Q1
$11.7M Sell
179,825
-22,032
-11% -$1.39M 0.06% 260
2013
Q4
$13.2M Sell
201,857
-11,577
-5% -$741K 0.07% 260
2013
Q3
$12.7M Buy
213,434
+9,043
+4% +$536K 0.06% 261
2013
Q2
$11.7M Buy
+204,391
New +$12.1M 0.06% 247

Other funds holding CL

ING Group's CL Position: Q2 2026 in Review

ING Group increased its Colgate-Palmolive (CL) stake by 56% in Q2 2026, buying an estimated $16.1M and bringing the position to 512,309 shares worth $47M. The position accounts for 0.23% of the portfolio, ranked #85.

ING Group first reported a position in CL in Q2 2013 and has held it in 51 quarters since. The position peaked at $49.4M in Q2 2023. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • ING Group held 512,309 shares of Colgate-Palmolive worth $47M as of Q2 2026.
  • ING Group bought 184,378 Colgate-Palmolive shares in Q2 2026, an estimated $16.1M.
  • Colgate-Palmolive made up 0.23% of ING Group's portfolio in Q2 2026, its #85 holding.
  • ING Group first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 51 quarters since.
  • ING Group's Colgate-Palmolive position peaked at $49.4M in Q2 2023.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on ING Group's 13F filing for Q2 2026, filed 13 Aug 2026.